IL-10 -1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort.

World Journal of Urology
Pravin KesarwaniRama D Mittal

Abstract

Chronic intraprostatic inflammation is suspected to play a major role in the pathogenesis of prostate cancer (PCa). Polymorphisms in interleukin-10 (IL-10), a key anti-inflammatory cytokine gene can influence immune response and immune evasion of tumor cells. Its role as an anti-metastatic molecule is also well documented. Gene promoter polymorphisms in IL-10 (-1082 G>A and -819 C>T) was analyzed in 159 PCa patients and 259 healthy controls to investigate their potential association with susceptibility for PCa. Our results indicated that the heterozygous (GA) and homozygous mutant (AA) genotypes of IL-10 -1082 to be more prevalent among PCa patients in comparison to controls (GA: OR - 2.8, p = 0.011; AA: OR - 2.3, p = 0.037). More patients (92.5%) than controls (82.7%) were positive for the A allele (GA + AA: OR - 2.6, p = 0.015). We observed lower frequency of T(-819)-G(-1082) haplotype in patients without bone metastasis (4.4%, OR - 0.30, p = 0.019) in comparison to PCa patients with bone metastasis (12.6%). Our results support the emerging hypothesis that genetically determined immune activity may play a role in the pathophysiology of PCa. Our findings of high producer of IL-10 -1082 variants suggest initiation of PCa. Futur...Continue Reading

References

Jan 1, 1992·International Archives of Allergy and Immunology·H Spits, R de Waal Malefyt
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Apr 1, 1995·The Journal of Allergy and Clinical Immunology·C J MeliskaJ M Martinko
Aug 1, 1996·The Journal of Experimental Medicine·L M ZhengI King
Feb 1, 1997·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·D M TurnerI V Hutchinson
Mar 10, 1999·Journal of the National Cancer Institute·L N KolonelR V Cooney
Aug 22, 2000·The Prostate·X FilellaA M Ballesta
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A W GibsonR P Kimberly
Oct 9, 2001·Epidemiologic Reviews·K HickeyA Green
Oct 9, 2001·Epidemiologic Reviews·R B Hayes
Jan 30, 2004·Cytokine & Growth Factor Reviews·Simone MocellinMario Lise
Nov 9, 2004·Advances in Cancer Research·Li Yang, David P Carbone
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Dec 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tanja EderKarin S Kapp
Mar 27, 2007·Nature Reviews. Cancer·Angelo M De MarzoWilliam G Nelson
Nov 14, 2007·Cancer Causes & Control : CCC·Jessica M Faupel-BadgerJoseph A Tangrea

❮ Previous
Next ❯

Citations

Feb 23, 2011·Prostate Cancer and Prostatic Diseases·N ShaoL-x Hua
Apr 24, 2012·Carcinogenesis·Ernest K AmankwahJong Y Park
Jan 8, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yan-Feng ZouFen Huang
Jan 1, 2010·Cancers·Elizabeth A TindallDesiree C Petersen
Oct 11, 2017·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Kapil BandilMausumi Bharadwaj
May 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Preetiner Pal SinghAparajita Khatri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here